225 related articles for article (PubMed ID: 31479538)
21. Retrospective evaluation of amphotericin B deoxycholate toxicity in a single centre series of haematopoietic stem cell transplantation recipients.
Annaloro C; Olivares C; Usardi P; Onida F; Della Volpe A; Tagliaferri E; Deliliers GL
J Antimicrob Chemother; 2009 Mar; 63(3):625-6. PubMed ID: 19158110
[No Abstract] [Full Text] [Related]
22. Feasibility, tolerability, and outcomes of nebulized liposomal amphotericin B for Aspergillus infection prevention in lung transplantation.
Monforte V; Ussetti P; Gavaldà J; Bravo C; Laporta R; Len O; García-Gallo CL; Tenorio L; Solé J; Román A
J Heart Lung Transplant; 2010 May; 29(5):523-30. PubMed ID: 20061165
[TBL] [Abstract][Full Text] [Related]
23. Recurrence of allergic bronchopulmonary aspergillosis after adjunctive surgery for aspergilloma: a case report with long-term follow-up.
Horiuchi K; Asakura T; Hasegawa N; Saito F
BMC Pulm Med; 2018 Dec; 18(1):185. PubMed ID: 30514257
[TBL] [Abstract][Full Text] [Related]
24. Twelve-month clinical outcomes of 206 patients with chronic pulmonary aspergillosis.
Bongomin F; Harris C; Hayes G; Kosmidis C; Denning DW
PLoS One; 2018; 13(4):e0193732. PubMed ID: 29634721
[TBL] [Abstract][Full Text] [Related]
25. Continuously infused amphotericin B deoxycholate for primary treatment of invasive fungal disease in acute myeloid leukaemia.
Rothenbühler C; Held U; Manz MG; Schanz U; Gerber B
Hematol Oncol; 2018 Apr; 36(2):471-480. PubMed ID: 29431860
[TBL] [Abstract][Full Text] [Related]
26. Multidimensional volumetric imaging of pulmonary infiltrates for measuring therapeutic response to antifungal therapy in experimental invasive pulmonary aspergillosis.
Petraitis V; Petraitiene R; Solomon J; Kelaher AM; Murray HA; Mya-San C; Bhandary AK; Sein T; Avila NA; Basevicius A; Bacher J; Walsh TJ
Antimicrob Agents Chemother; 2006 Apr; 50(4):1510-7. PubMed ID: 16569871
[TBL] [Abstract][Full Text] [Related]
27. Should we continue using amphotericin B deoxycholate for the treatment of fungal infections? Adverse events and clinical outcomes.
Garbino J; Markham L; Matulionyte R; Rives V; Lew D
Scand J Infect Dis; 2006; 38(2):110-3. PubMed ID: 16449001
[TBL] [Abstract][Full Text] [Related]
28. Comparative study on the efficacy of AmBisome and Fungizone in a mouse model of pulmonary aspergillosis.
Takemoto K; Yamamoto Y; Ueda Y; Sumita Y; Yoshida K; Niki Y
J Antimicrob Chemother; 2006 Apr; 57(4):724-31. PubMed ID: 16446374
[TBL] [Abstract][Full Text] [Related]
29. A pilot randomized trial of nebulized amphotericin in patients with allergic bronchopulmonary aspergillosis.
Ram B; Aggarwal AN; Dhooria S; Sehgal IS; Garg M; Behera D; Chakrabarti A; Agarwal R
J Asthma; 2016 Jun; 53(5):517-24. PubMed ID: 26666774
[TBL] [Abstract][Full Text] [Related]
30. Allergic bronchopulmonary aspergillosis and related allergic syndromes.
Hogan C; Denning DW
Semin Respir Crit Care Med; 2011 Dec; 32(6):682-92. PubMed ID: 22167396
[TBL] [Abstract][Full Text] [Related]
31. Nebulised amphotericin B-polymethacrylic acid nanoparticle prophylaxis prevents invasive aspergillosis.
Shirkhani K; Teo I; Armstrong-James D; Shaunak S
Nanomedicine; 2015 Jul; 11(5):1217-26. PubMed ID: 25791815
[TBL] [Abstract][Full Text] [Related]
32. Biodistribution and histopathology studies of amphotericin B sodium deoxycholate sulfate formulation following intratracheal instillation in rat models.
Usman F; Nopparat J; Javed I; Srichana T
Drug Deliv Transl Res; 2020 Feb; 10(1):59-69. PubMed ID: 31368043
[TBL] [Abstract][Full Text] [Related]
33. Serum IgE and IgG reactivity to Aspergillus recombinant antigens in patients with cystic fibrosis.
Alghamdi NS; Barton R; Wilcox M; Peckham D
J Med Microbiol; 2019 Jun; 68(6):924-929. PubMed ID: 31090534
[TBL] [Abstract][Full Text] [Related]
34. What is the current and future status of conventional amphotericin B?
Kleinberg M
Int J Antimicrob Agents; 2006 Jun; 27 Suppl 1():12-6. PubMed ID: 16707251
[TBL] [Abstract][Full Text] [Related]
35. [Aspergillosis in pulmonary transplantation].
de Pablo A; Ussetti P; Cruz Carreño M; Lázaro T; Ferreiro MJ; López A; Mendaza P; Estada J
Enferm Infecc Microbiol Clin; 2000 May; 18(5):209-14. PubMed ID: 10974763
[TBL] [Abstract][Full Text] [Related]
36. Pulmonary aspergillosis: clinical presentation, diagnostic tests, management and complications.
Sherif R; Segal BH
Curr Opin Pulm Med; 2010 May; 16(3):242-50. PubMed ID: 20375786
[TBL] [Abstract][Full Text] [Related]
37. The effects of antifungal therapy on severe asthma with fungal sensitization and allergic bronchopulmonary aspergillosis.
Pasqualotto AC; Powell G; Niven R; Denning DW
Respirology; 2009 Nov; 14(8):1121-7. PubMed ID: 19909460
[TBL] [Abstract][Full Text] [Related]
38. Pulmonary Aspergillus Overlap Syndromes.
Li L; Jiang Z; Shao C
Mycopathologia; 2018 Apr; 183(2):431-438. PubMed ID: 29067630
[TBL] [Abstract][Full Text] [Related]
39. Addition of aerosolized deoxycholate amphotericin B to systemic prophylaxis to prevent airways invasive fungal infections in allogeneic hematopoietic SCT: a single-center retrospective study.
Morello E; Pagani L; Coser P; Cavattoni I; Cortelazzo S; Casini M; Billio A; Rossi G
Bone Marrow Transplant; 2011 Jan; 46(1):132-6. PubMed ID: 20383205
[TBL] [Abstract][Full Text] [Related]
40. Elevated serum levels of periostin in patients with allergic bronchopulmonary aspergillosis.
Wu G; Meng X; Zheng P; Zhang XD; Li L; Hu H; Sun B
Mycoses; 2019 Sep; 62(9):780-789. PubMed ID: 31173398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
